Evidence map›Paper›PMID 21552562›Full record

ArticlePloS one2011

Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages.

Nilda E Rodríguez, Upasna Gaur Dixit, Lee-Ann H Allen, Mary E Wilson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Peptide selection via phage display to inhibitFrontiers in microbiology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Challenges and Tools for In VitroPathogens (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Article
  9. Caveolae as Potential Hijackable Gates in Cell Communication.Frontiers in cell and developmental biology · 2020
    Review
  10. Article
  11. TheThe Yale journal of biology and medicine · 2019
    Review
  12. Review
  13. Epidemiological and Experimental Evidence for Sex-Dependent Differences in the Outcome ofThe American journal of tropical medicine and hygiene · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nilda E RodríguezVeterans' Affairs Medical Center, Iowa City, Iowa, United States of America. nilda-rodriguez@uiowa.edu
Upasna Gaur Dixit
Lee-Ann H Allen
Mary E Wilson
Veterans Health Administration · USIowa City VA Medical Center · USUniversity of Iowa · US

Funding

Protective Immunity to Leishmania chagasiR01AI045540 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY E · 2001 to 2011
$3.1M
Collaborative Development of a Vaccine against Cutaneous and Visceral LeishmaniasR01AI067874 · NIAID · UNIVERSITY OF IOWA · PI WILSON, MARY E · 2006 to 2010
$2.2M
NIAID NIH HHS AI045540NIAID NIH HHS AI067874NIAID NIH HHS R01 AI045540NIAID NIH HHS R01 AI067874
6 · The paper itself

Abstract

The life stages of Leishmania spp. include the infectious promastigote and the replicative intracellular amastigote. Each stage is phagocytosed by macrophages during the parasite life cycle. We previously showed that caveolae, a subset of cholesterol-rich membrane lipid rafts, facilitate uptake and intracellular survival of virulent promastigotes by macrophages, at least in part, by delaying parasitophorous vacuole (PV)-lysosome fusion. We hypothesized that amastigotes and promastigotes would differ in their route of macrophage entry and mechanism of PV maturation. Indeed, transient disruption of macrophage lipid rafts decreased the entry of promastigotes, but not amastigotes, into macrophages (P<0.001). Promastigote-containing PVs were positive for caveolin-1, and co-localized transiently with EEA-1 and Rab5 at 5 minutes. Amastigote-generated PVs lacked caveolin-1 but retained Rab5 and EEA-1 for at least 30 minutes or 2 hours, respectively. Coinciding with their conversion into amastigotes, the number of promastigote PVs positive for LAMP-1 increased from 20% at 1 hour, to 46% by 24 hours, (P<0.001, Chi square). In contrast, more than 80% of amastigote-initiated PVs were LAMP-1+ at both 1 and 24 hours. Furthermore, lipid raft disruption increased LAMP-1 recruitment to promastigote, but not to amastigote-containing compartments. Overall, our data showed that promastigotes enter macrophages through cholesterol-rich domains like caveolae to delay fusion with lysosomes. In contrast, amastigotes enter through a non-caveolae pathway, and their PVs rapidly fuse with late endosomes but prolong their association with early endosome markers. These results suggest a model in which promastigotes and amastigotes use different mechanisms to enter macrophages, modulate the kinetics of phagosome maturation, and facilitate their intracellular survival.

Indexed as

Life Cycle StagesAnimalsCaveolin 1CholesterolCricetinaeLeishmania infantumMacrophagesMaleMembrane MicrodomainsMiceMice, Inbred BALB CPhagocytosisPhagosomesCaveolin 1Cholesterol

Identifiers

PMID21552562
PMCPMC3084250
OpenAlexW2000563102

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.